{
  "docId": "019de075-5029-738c-8512-9456f77efe7c",
  "docSlug": "25c628cfc0779f52594519f9e322dc70",
  "documentTitle": "Genelux | Investor Presentation Deck | 38 slides",
  "authorId": "genelux",
  "authorName": "Genelux",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 30,
  "pageCount": 38,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "timeline",
  "function": "show_traction",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide uses a split layout: a list for past achievements and an arrow-based timeline for future goals.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-5029-738c-8512-9456f77efe7c/30",
  "deckHref": "/decks/019de075-5029-738c-8512-9456f77efe7c",
  "deckJsonHref": "/decks/019de075-5029-738c-8512-9456f77efe7c.json",
  "deckAnchorHref": "/decks/019de075-5029-738c-8512-9456f77efe7c#slide-30",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.62,
        "x": 0.33,
        "y": 0.16
      },
      "kind": "diagram",
      "text": "Initiate Phase 2 trial in (Adjuvant Maintenance) NSCLC; Enter additional regional development & commercial partnership(s) and platform collaborations; Initiate Phase 1/2 trial in recurrent ovarian cancer (IV route); Initiate Ph1b/2 trial of V2ACT",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a132422-47b2-4db8-9283-16d006f38247",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.27,
        "x": 0.03,
        "y": 0.185
      },
      "kind": "list",
      "text": "Executed on go public strategy and follow on with $60M raised; Initation of Phase 3 Trial in PRROC; Phase 2 results published in JAMA Oncology; Collaboration and License agreement with Newsoara; Initiation of Phase 1b/2 trial in recurrent SCLC (China); Issuance of V2ACT US Patent",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12fd69b9-4821-4e2a-af1f-664a60087232",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.94,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Genelux Has Executed on Multiple Milestones and is Positioned for the Future",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bd13a0f1-c388-4e42-8f1e-ed170e3c64fe",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "745fc0a5-d633-45d7-accc-0ceb8de14b88",
      "evidence": "The slide uses a chronological arrow to represent future milestones.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 30,
      "from": 29,
      "beatId": "961a80e1-0c4a-4702-b1a1-8e78394e0cb0",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Team",
      "beatSlug": "sequoia-pitch-team",
      "evidence": "The presentation showcases the leadership team and their accomplishments, highlighting their ability to execute on the company's vision.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}